Goldman Sachs Initiates Coverage of Solventum (SOLV) with Sell Recommendation

Fintel reports that on May 30, 2024, Goldman Sachs initiated coverage of Solventum (NYSE:SOLV) with a Sell recommendation.

Analyst Price Forecast Suggests 18.99% Upside

As of May 22, 2024, the average one-year price target for Solventum is 71.06. The forecasts range from a low of 69.69 to a high of $73.50. The average price target represents an increase of 18.99% from its latest reported closing price of 59.72.

See our leaderboard of companies with the largest price target upside.

The projected annual revenue for Solventum is 8,248MM, an increase of 0.56%. The projected annual non-GAAP EPS is 6.39.

What are Other Shareholders Doing?

SOLV / Solventum Corporation Shares Held by Institutions

Geode Capital Management holds 2,734K shares.

Candlestick Capital Management holds 320K shares.

Citadel Advisors holds 280K shares.

Royal Bank Of Canada holds 205K shares.

Clark Estates holds 135K shares.

Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.

Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.

Click to Learn More

This story originally appeared on Fintel.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


More Related Articles

Info icon

This data feed is not available at this time.

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.